Endocrinology, Vol 134, 1082-1088, Copyright © 1994 by Endocrine Society

ARTICLES

Recombinant bovine somatotropin blunts plasma tumor necrosis factor- alpha, cortisol, and thromboxane-B2 responses to endotoxin in vivo

TH Elsasser, R Fayer, TS Rumsey and GF Hartnell
Ruminant Nutrition Laboratory, U.S. Department of Agricultural, Agricultural Research Service, Beltsville, Maryland 20705.

In vivo studies determined the effects of recombinant bovine somatotropin (bST; sometribove) administration (0.1 mg/kg.day, im) to calves on the increases in plasma immunoreactive tumor necrosis factor- alpha (TNF alpha), prostacyclin [6-keto-prostaglandin F1 alpha (6KP)], thromboxane-B2 (TXB), and cortisol (C) that occurred after endotoxin challenge (ET). Two ETs were administered 5 days apart to test the effect of bST on the natural attenuation of hormone and cytokine responses that occurs after repeated challenge with endotoxin. Calves (n = 6) were treated with bST for 5 days. On day 6, the first ET was administered (Escherichia coli; 055:B5; 0.2 microgram/kg, i.v.). Blood was sampled before and hourly after ET through 6 h. For the next 4 days, bST injections continued, and ET was repeated 1 day later. Six additional calves were treated with bicarbonate buffer as contemporary controls for the bST and were similarly challenged with endotoxin. Plasma TNF alpha, C, 6KP, and TXB were significantly increased after each ET. The increases in TNF alpha, C, and TXB were blunted after the second Et compared to those after the first in both untreated and bST- treated animals. The increases in plasma TNF alpha and C and peak plasma TXB and TXB/6KP ratios were smaller in bST-treated than in untreated after the first ET. TNF alpha receptor binding was studied in hepatic microsomal fractions from three bST-treated and three untreated calves. Microsomal fractions from bST-treated calves bound 40% less TNF alpha (5.97 vs. 9.96 pmol/mg) than similar fractions from controls. The data indicate that bST decreases TNF alpha, TXB, and C responses to ET and reduces the TNF alpha-binding capacity of hepatic membranes, suggesting a multiplicity of sites where bST might affect the physiological response to endotoxin.

This article has been cited by other articles:

				J. A. Carroll Bidirectional communication: Growth and immunity in domestic livestock J Anim Sci, April 1, 2008; 86(14_suppl): E126 - E137. [Abstract] [Full Text] [PDF]

				L. A. Winkelman, T. H. Elsasser, and C. K. Reynolds Limit-Feeding a High-Energy Diet to Meet Energy Requirements in the Dry Period Alters Plasma Metabolite Concentrations but Does Not Affect Intake or Milk Production in Early Lactation J Dairy Sci, March 1, 2008; 91(3): 1067 - 1079. [Abstract] [Full Text] [PDF]

				T. H. Elsasser, J. W. Blum, and S. Kahl Characterization of calves exhibiting a novel inheritable TNF-{alpha} hyperresponsiveness to endotoxin: associations with increased pathophysiological complications J Appl Physiol, June 1, 2005; 98(6): 2045 - 2055. [Abstract] [Full Text] [PDF]

				T. H. Elsasser, S. Kahl, C. MacLeod, B. Nicholson, J. L. Sartin, and C. Li Mechanisms Underlying Growth Hormone Effects in Augmenting Nitric Oxide Production and Protein Tyrosine Nitration during Endotoxin Challenge Endocrinology, July 1, 2004; 145(7): 3413 - 3423. [Abstract] [Full Text] [PDF]

				T. K. Hansen, S. Fisker, R. Dall, T. Ledet, J. O. L. Jorgensen, and L. M. Rasmussen Growth Hormone Increases Vascular Cell Adhesion Molecule 1 Expression: in Vivo and in Vitro Evidence J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 909 - 916. [Abstract] [Full Text] [PDF]

				J. L. Sartin, T. H. Elsasser, S. Kahl, J. Baker, J. A. Daniel, D. D. Schwartz, B. Steele, and B. K. Whitlock Estradiol plus progesterone treatment modulates select elements of the proinflammatory cytokine cascade in steers: Attenuated nitric oxide and thromboxane B2 production in endotoxemia J Anim Sci, June 1, 2003; 81(6): 1546 - 1551. [Abstract] [Full Text] [PDF]

				T. K. Hansen, S. Thiel, R. Dall, A. M. Rosenfalck, P. Trainer, A. Flyvbjerg, J. O. L. Jorgensen, and J. S. Christiansen GH Strongly Affects Serum Concentrations of Mannan-Binding Lectin: Evidence for a New IGF-I Independent Immunomodulatory Effect of GH J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5383 - 5388. [Abstract] [Full Text] [PDF]

				N. M. Filipov, F. N. Thompson, J. A. Stuedemann, T. H. Elsasser, S. Kahl, L. H. Stanker, C. R. Young, D. L. Dawe, and C. K. Smith Anti-Inflammatory Effects of Ergotamine in Steers Experimental Biology and Medicine, November 1, 2000; 225(2): 136 - 142. [Abstract] [Full Text]

				S. H. Zarkesh-Esfahani, O. Kolstad, R. A. Metcalfe, P. F. Watson, S. Von Laue, S. Walters, A. Revhaug, A. P. Weetman, and R. J. M. Ross High-Dose Growth Hormone Does Not Affect Proinflammatory Cytokine (Tumor Necrosis Factor-{alpha}, Interleukin-6, and Interferon-{gamma}) Release from Activated Peripheral Blood Mononuclear Cells or after Minimal to Moderate Surgical Stress J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3383 - 3390. [Abstract] [Full Text]

				J. Takala, E. Ruokonen, N. R. Webster, M. S. Nielsen, D. F. Zandstra, G. Vundelinckx, and C. J. Hinds Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults N. Engl. J. Med., September 9, 1999; 341(11): 785 - 792. [Abstract] [Full Text] [PDF]

				W. Liao, M. Rudling, and B. Angelin Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor I on the Biological Activities of Endotoxin in the Rat Endocrinology, January 1, 1997; 138(1): 289 - 295. [Abstract] [Full Text] [PDF]